BioPlus Acquisition Corp Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BioPlus Acquisition are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days BioPlus Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BioPlus Acquisition is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 635.5 K |
BioPlus |
BioPlus Acquisition Relative Risk vs. Return Landscape
If you would invest (100.00) in BioPlus Acquisition Corp on December 4, 2024 and sell it today you would earn a total of 100.00 from holding BioPlus Acquisition Corp or generate -100.0% return on investment over 90 days. BioPlus Acquisition Corp is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than BioPlus, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
BioPlus Acquisition Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioPlus Acquisition's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioPlus Acquisition Corp, and traders can use it to determine the average amount a BioPlus Acquisition's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BIOSW |
Based on monthly moving average BioPlus Acquisition is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioPlus Acquisition by adding BioPlus Acquisition to a well-diversified portfolio.
BioPlus Acquisition Fundamentals Growth
BioPlus Stock prices reflect investors' perceptions of the future prospects and financial health of BioPlus Acquisition, and BioPlus Acquisition fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioPlus Stock performance.
| EBITDA | (1.17 M) | |||
| Cash And Equivalents | 936 | |||
| Total Debt | 5 M | |||
| Debt To Equity | 7.23 % | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (691.47 K) | |||
| Total Asset | 238.32 M | |||
| Retained Earnings | (14.78 M) | |||
Things to note about BioPlus Acquisition Corp performance evaluation
Checking the ongoing alerts about BioPlus Acquisition for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioPlus Acquisition Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioPlus Acquisition is not yet fully synchronised with the market data | |
| BioPlus Acquisition has some characteristics of a very speculative penny stock | |
| BioPlus Acquisition has a very high chance of going through financial distress in the upcoming years | |
| BioPlus Acquisition Corp has accumulated about 936 in cash with (691.47 K) of positive cash flow from operations. |
- Analyzing BioPlus Acquisition's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioPlus Acquisition's stock is overvalued or undervalued compared to its peers.
- Examining BioPlus Acquisition's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioPlus Acquisition's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioPlus Acquisition's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioPlus Acquisition's stock. These opinions can provide insight into BioPlus Acquisition's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |